CDAK
NASDAQ:CDAK
VentureRadar
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.codiakbio.comipo date
Oct 14, 2020
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The compan...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus